Home Cart Sign in  
Chemical Structure| 10605-02-4 Chemical Structure| 10605-02-4

Structure of Palmatine chloride
CAS No.: 10605-02-4

Chemical Structure| 10605-02-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Palmatine chloride an isoquinoline alkaloid, is an important medicinal herbal extract with diverse pharmacological and biological properties.

Synonyms: Palmatine (chloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Palmatine chloride

CAS No. :10605-02-4
Formula : C21H22ClNO4
M.W : 387.86
SMILES Code : COC1=C(OC)C2=C[N+]3=C(C4=CC(OC)=C(OC)C=C4CC3)C=C2C=C1.[Cl-]
Synonyms :
Palmatine (chloride)
MDL No. :MFCD00016656
InChI Key :RLQYRXCUPVKSAW-UHFFFAOYSA-M
Pubchem ID :73442

Safety of Palmatine chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332
Precautionary Statements:P261-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312

Related Pathways of Palmatine chloride

epigenetics
DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PANC-1 cells 75, 150 μg/mL 48 h PMT inhibited the growth of PANC-1 cells but did not significantly affect survivin expression or apoptosis. PMC5858579
MIA PaCa-2 cells 75, 150 μg/mL 30 h PMT reduced the protein levels of GLI2 and PTCH1, significantly decreased the expression of survivin, and induced apoptosis. PMC5858579
Human pancreatic stellate cells (PSCs) 75, 150 μg/mL 24, 48 h PMT inhibited the expression and protein levels of GLI1 and GLI2, reduced GLI reporter activity, and downregulated the expression of PTCH1, IκBε, and COL1A1. PMT also reduced the proliferation and colony-forming ability of PSCs and inhibited their invasive ability. PMC5858579
Rat colonic mucosa 1–300 µM 30 min To assess the effects of Palmatine on active ion transport across rat colonic epithelium, results showed that Palmatine inhibited carbachol-induced Ca2+-activated Cl- secretion and the carbachol-induced increase of intracellular Ca2+ concentration. PMC2275457
THP-1 macrophages 20, 40, 80 μM 1 h PAL dose-dependently decreased the mRNA expression and levels of pro-inflammatory cytokines (IL-1β, IL-6, IL-18, and TNF-α), inhibited the NF-κB/NLRP3 signaling pathway, and enhanced the expression of antioxidant proteins Nrf2 and HO-1. PMC9259749

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Chronic spontaneous urticaria model Oral 40 mg/kg Once daily for 10 days To investigate the protective effect of Palmatine on CSU rats. Results showed that Palmatine effectively alleviated skin lesions, reduced itching and mast cell degranulation, significantly decreased inflammatory factors, and activated autophagy-related protein expression. PMC10682667
Zebrafish PTZ-induced seizure model Not specified 450 µM 24 hours To evaluate the effect of Palmatine on PTZ-induced seizures, results showed that Palmatine exhibited antiseizure activity, reducing PTZ-induced epileptiform-like discharges and hyperlocomotion. PMC7290958
Zebrafish TNBS-induced inflammatory bowel disease model Embryo medium 200 μM From 24 hours before TNBS treatment until the end of the analysis To evaluate the regulatory effects of Palmatine on intestinal inflammation, results showed that Palmatine significantly suppressed the accumulation of neutrophils in the intestinal tracts PMC8166029
KM mice MSU-induced gouty arthritis model Oral 25, 50, 100 mg/kg Once daily for 24 hours PAL alleviated MSU-induced gouty arthritis inflammation, as evidenced by reduced joint swelling, decreased levels of IL-1β, IL-6, IL-18, TNF-α, and MDA, while increasing the levels of SOD and GSH. Additionally, PAL reduced the infiltration of neutrophils into the joint synovium. PMC9259749

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.89mL

2.58mL

1.29mL

25.78mL

5.16mL

2.58mL

References

 

Historical Records

Categories